3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
36
Lung Neoplasms
17
Colonic Neoplasms
15
Rectal Neoplasms
13
Colorectal Neoplasms
13
Uterine Cervical Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Prostatic Neoplasms
10
Neoplasms
9
Lymphoma
8
Urinary Bladder Neoplasms
7
Leukemia
7
Endometrial Neoplasms
7
Leukemia, Myeloid, Acute
6
Depression
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Pain
5
Multiple Myeloma
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Carcinoma, Ovarian Epithelial
5
Burkitt Lymphoma
5
Breast Carcinoma In Situ
5
Small Cell Lung Carcinoma
4
Primary Myelofibrosis
4
Papillomavirus Infections
4
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Interventions
Dexamethasone
22
Ondansetron
20
Aprepitant
20
Palonosetron
17
Granisetron
11
Calcium Dobesilate
8
Therapeutics
7
Olanzapine
6
dexamethasone acetate
5
Doxorubicin
5
Cyclophosphamide
5
casopitant
4
Acupressure
4
netupitant
3
dolasetron
3
Yoga
3
Vincristine
3
Radiotherapy
3
Dronabinol
3
Analgesia
3
ginger extract
2
fosaprepitant
2
dexamethasone 21-phosphate
2
Tropisetron
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Prochlorperazine
2
Metoclopramide
2
Mesna
2
Ifosfamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Nausea
×
Early Intervention, Educational
×
Clear all
NCT01590147
2018-08-15
SIPS
Wake Forest University Health Sciences
Phase NA
Completed
15 enrolled